Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

In the ever-evolving landscape of healthcare technology, the Artificial Pancreas Device System stands out as a beacon of hope ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

Beta-blockers are one of the first-line medications often prescribed for migraine prevention. Discover the benefits, side ...

Medtronic plc a global leader in medical technology, announced its intent to spin off its Diabetes business into a entity ...

The US Food and Drug Administration approved the first-ever rapid-acting insulin for reducing blood ... that occur during mealtime. Also, the FDA approved Merilog’s 3-milliliter single-patient ...

Merilog is a rapid-acting human insulin analog and the first rapid-acting insulin biosimilar product approved by the FDA. Administering Merilog subcutaneously 5 to 10 minutes before mealtime helps ...